_edited.png)
Klow Capsules
$150.00
KLOW Capsules
Advanced Multi-Peptide Research Formula | 60 Capsules | Made in USA | Research Use Only
KLOW Capsules represent a next-generation multi-peptide research blend formulated for laboratories seeking a synergistic combination of regenerative signaling, tissue pathway analysis, and advanced peptide stack investigation in capsule format.
Each bottle contains 60 precisely formulated capsules, engineered for advanced laboratory research applications involving:
GHK-Cu (Copper Tripeptide-1) – 1mg per capsule
KPV Peptide – 500mcg per capsule
BPC-157 – 500mcg per capsule
TB500 (Thymosin Beta-4 Fragment) – 500mcg per capsule
Manufactured in the USA under strict quality control standards, KLOW Capsules are designed for controlled research environments requiring multi-pathway peptide investigation.
Precision-Formulated Multi-Peptide Matrix
GHK-Cu (Copper Peptide) – 1mg
Extensively studied for its role in cellular signaling, extracellular matrix support, and copper-binding activity in regenerative biology research models.
KPV (Lys-Pro-Val) – 500mcg
A tripeptide fragment of alpha-MSH commonly researched for inflammatory signaling pathways and epithelial tissue modeling applications.
BPC-157 – 500mcg
A synthetic pentadecapeptide utilized in laboratory research focused on angiogenesis pathways, peptide signaling cascades, and tissue interaction studies.
TB500 (Thymosin Beta-4 Fragment) – 500mcg
Studied for its interaction with actin regulation, cellular migration processes, and tissue response mechanisms.
Why Researchers Choose KLOW Capsules
Multi-peptide synergy in one capsule
60 capsules per bottle
Precisely measured milligram and microgram concentrations
USA manufactured
Designed for advanced peptide research protocols
Encapsulated for stability and laboratory handling convenience
KLOW Capsules provide a comprehensive peptide research stack combining copper-binding peptides, anti-inflammatory signaling fragments, angiogenic research compounds, and cytoskeletal modulators in a single streamlined formula.
Product Specifications
Product Name: KLOW Capsules
Capsule Count: 60 Capsules Per Bottle
GHK-Cu: 1mg per capsule
KPV: 500mcg per capsule
BPC-157: 500mcg per capsule
TB500: 500mcg per capsule
Manufactured In: USA
Intended Use: For Research Purposes Only
Important Notice
This product is strictly intended for laboratory research purposes only.
Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Quantity
GHK-CU Compound
Compound CID: 9831891
MF: C28H46CuN12O8
MW: 742.3 g/mol
IUPAC Name: copper bis((2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate)
SMILES: C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)[O-])NC(=O)CN.C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)[O-])NC(=O)CN.[Cu+2]
InChIKey: YINACRBQQGZRRM-XTQNZXNBSA-L
InChI: InChI=1S/2C14H24N6O4.Cu/c2*15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;/h2*7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24);/q;;+2/p-2/t2*10-,11-;/m00./s1
Create Date: 2006-10-25
BPC-157 Compound
Compound CID: 9941957
MF: C62H98N16O22
MW: 1419.5 g/mol
IUPAC Name: (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
SMILES: C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)CN
InChIKey: HEEWEZGQMLZMFE-RKGINYAYSA-N
InChI: InChI=1S/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1
Create Date: 2006-10-25
TB500 Compound
Compound CID: 62707662
MF: C38H68N10O14
MW: 889.0 g/mol
IUPAC Name: (2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid
SMILES: C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)C)O
InChIKey: ADKDNDYYIZUVCZ-ZQNQAVPYSA-N
InChI: InChI=1S/C38H68N10O14/c1-19(2)18-27(42-22(5)51)35(58)44-23(10-6-8-16-39)32(55)43-24(11-7-9-17-40)33(56)47-30(20(3)49)36(59)45-25(13-15-29(53)54)34(57)48-31(21(4)50)37(60)46-26(38(61)62)12-14-28(41)52/h19-21,23-27,30-31,49-50H,6-18,39-40H2,1-5H3,(H2,41,52)(H,42,51)(H,43,55)(H,44,58)(H,45,59)(H,46,60)(H,47,56)(H,48,57)(H,53,54)(H,61,62)/t20-,21-,23+,24+,25+,26+,27+,30+,31+/m1/s1
Create Date: 2012-10-22
Trusted by Labs. Built for Precision.
3rd-Party Lab Tested
Every batch is independently tested for purity and quality.
≥99% Purity Guarantee
Our peptides meet or exceed research-grade standards.
Fast U.S. Shipping
Orders ship quickly and discreetly from U.S. warehouses.
Research-Use Only
Properly labeled and handled for licensed research use.